K. Peony Yu
2016
In 2016, K. Peony Yu earned a total compensation of $2.1M as Chief Medical Officer at FibroGen, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,992 |
|---|---|
| Option Awards | $686,196 |
| Salary | $463,000 |
| Stock Awards | $684,351 |
| Other | $16,976 |
| Total | $2,096,515 |
Yu received $686.2K in option awards, accounting for 33% of the total pay in 2016.
Yu also received $246K in non-equity incentive plan, $463K in salary, $684.4K in stock awards and $17K in other compensation.
Rankings
In 2016, K. Peony Yu's compensation ranked 4,668th out of 14,075 executives tracked by ExecPay. In other words, Yu earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,668 out of 14,075 | 67th |
Division Manufacturing | 1,659 out of 5,486 | 70th |
Major group Chemicals And Allied Products | 516 out of 1,900 | 73rd |
Industry group Drugs | 381 out of 1,543 | 75th |
Industry Pharmaceutical Preparations | 301 out of 1,173 | 74th |
Source: SEC filing on April 24, 2017.
Yu's colleagues
We found three more compensation records of executives who worked with K. Peony Yu at FibroGen in 2016.